Baker Brothers Advisors - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 31 filers reported holding CYTEIR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,111,995
-19.0%
2,492,118
-5.7%
0.02%
-24.2%
Q3 2022$5,076,000
-35.8%
2,643,6400.0%0.03%
-26.7%
Q2 2022$7,904,000
+158.0%
2,643,640
+225.3%
0.04%
+150.0%
Q1 2022$3,064,000
-66.8%
812,6400.0%0.02%
-60.0%
Q4 2021$9,240,000
-35.2%
812,6400.0%0.04%
-28.6%
Q3 2021$14,262,000
-18.0%
812,6400.0%0.06%
-17.1%
Q2 2021$17,390,000812,6400.08%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,459,572$6,985,18415.71%
BML Capital Management, LLC 3,250,008$9,230,0238.48%
Newtyn Management, LLC 2,500,444$7,101,2611.75%
VR Advisory Services Ltd 1,072,968$3,047,2291.08%
Anson Funds Management LP 1,324,114$3,760,4840.76%
Acuitas Investments, LLC 329,164$934,8260.55%
Aldebaran Capital, LLC 143,739$408,2190.42%
Bulldog Investors, LLP 200,000$568,0000.20%
GABELLI & Co INVESTMENT ADVISERS, INC. 416,200$1,182,0080.19%
Alta Fundamental Advisers LLC 117,346$333,2630.16%
View complete list of CYTEIR THERAPEUTICS INC shareholders